BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 306 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2024. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 781,539 | $49,925,000 | 7.34% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,921,347 | $122,736,000 | 6.13% |
| Casdin Capital, LLC | 1,550,000 | $99,014,000 | 4.44% |
| DAFNA Capital Management LLC | 246,280 | $15,732,000 | 4.10% |
| Nextech Invest Ltd. | 188,228 | $12,024,000 | 3.43% |
| Eagle Health Investments LP | 170,551 | $10,895,000 | 2.68% |
| Integral Health Asset Management, LLC | 153,000 | $9,774,000 | 2.54% |
| Boxer Capital, LLC | 507,374 | $32,411,000 | 1.67% |
| Rock Springs Capital Management LP | 947,715 | $60,540,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 136,691 | $8,730,000 | 1.31% |